Medication switch
semaglutide → tirzepatide — re-titration required
Patient developed type 2 diabetes — switch from weight-loss-labeled to diabetes-labeled tirzepatide.
Medically reviewed by Dr. Jane Novak, MD, MPH on May 15, 2026
Cross-ingredient switch — re-titration required
Wegovy uses semaglutide; Mounjaro uses tirzepatide. You restart from the starter dose and re-titrate over 12–20 weeks to reduce GI side effects.
These medications use different active ingredients (semaglutide vs. tirzepatide). Re-titration from the starter dose is required to reduce GI side effects.
Stop Wegovy. Start Mounjaro 2.5 mg for 4 weeks, then escalate every 4 weeks. Most patients with combined diabetes + weight goals stabilize at 10-15 mg.
GI symptoms commonly return during titration. Improved A1C control becomes visible within 8-12 weeks.
Mounjaro requires confirmed type 2 diabetes diagnosis. Insurance coverage for diabetes is generally broader than weight-management coverage.
Our ranked telehealth providers handle switching prescriptions, prior authorizations, and pharmacy coordination — typically 1–3 business days end to end.
See top providersEditorial ranking is independent of commission rates.
It is a reasonable conversation with your prescriber. Mounjaro is FDA-approved for diabetes, often with better insurance coverage than Wegovy weight loss. Re-titration from the starter dose is required because the active ingredient changes.
Reverse direction
Mounjaro → Wegovy
Other from Wegovy
Wegovy → Ozempic
Other from Wegovy
Wegovy → Zepbound
Other to Mounjaro
Zepbound → Mounjaro
Other to Mounjaro
Ozempic → Mounjaro
Resources for patients moving from Wegovy to Mounjaro.
Drug overview
FDA-label overview of Mounjaro (tirzepatide) with dosing schedule and contraindications.
ReadDrug overview
What you're switching from. Pricing, indications, and patient experience.
ReadLive data
Check current Mounjaro availability and which doses are limited.
ReadFree tool
Decision tree based on FDA criteria. Flags contraindications.
ReadFree tool
Draft a payer-ready PA letter your prescriber can sign in minutes.
ReadRanked & reviewed
Telehealth providers ranked by price, ratings, and insurance.
Read